ESOPJun 5, 2026, 07:01 AM
Tango Therapeutics Grants 170,000 Stock Options, 40,000 RSUs
AI Summary
Tango Therapeutics announced that its Compensation Committee granted a non-qualified stock option to purchase 170,000 shares and 40,000 restricted stock units (RSUs) to a new employee. These awards were made effective June 1, 2026, under the company's 2023 Inducement Plan, which is used for equity awards to new hires. The options have an exercise price of $23.10 per share and both awards are subject to specific vesting schedules and continued employment.
Key Highlights
- Granted 170,000 non-qualified stock options to a new employee.
- Granted 40,000 restricted stock units (RSUs) to a new employee.
- Awards effective June 1, 2026, under the 2023 Inducement Plan.
- Stock options have an exercise price of $23.10 per share.
- Options vest 25% on first anniversary, then 1/36th of remaining shares monthly.
- RSUs vest in three equal annual installments.
Price Impact
More from TNGX